Survival-adjusted health-related quality of life (HRQL) among patients with metastatic breast cancer receiving paclitaxel plus bevacizumab versus paclitaxel alone: results from Eastern Cooperative Oncology Group Study 2100 (E2100)

The purpose of this study was to examine health-related quality of life (HRQL) among women with metastatic breast cancer treated on E2100 with paclitaxel or paclitaxel plus bevacizumab. Trial participants (N = 670) completed the Functional Assessment of Cancer Therapy-Breast (FACT-B) pre-treatment a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Cella, David, Wang, Molin, Wagner, Lynne, Miller, Kathy
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684040/
https://ncbi.nlm.nih.gov/pubmed/21874312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-011-1725-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki